Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'rn 1 dihydrochloride'

Search results for: 'rn 1 dihydrochloride'

Items 21-30 of 45

Page
per page
  1. PD173955
    A8812 PD173955
    Target: Bcr-Abl|Src
    Summary: Dual Src/Abl kinase inhibitor, ATP-competitive,
      ≥22.15 mg/mL
  2. SU5416
    A3847 SU5416
    Target: VEGFR
    Summary: VEGF receptor inhibitor and AHR agonist
      insoluble in EtOH; insoluble in H2O; ≥11.9 mg/mL
  3. Sunitinib malate
    A8255 Sunitinib malate
     2 Citation
    Target: VEGFR
    Summary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
      ≥26.65 mg/mL
  4. PRT062607 Hydrochloride
    A3736 PRT062607 Hydrochloride
     1 Citation
    Target: Syk
    Summary: SYK inhibitor,potent and selective
      ≥21.5 mg/mL
  5. GW2580
    A1655 GW2580
     1 Citation
    Target: CSF-1R
    Summary: CFMS kinase/CSF-1R inhibitor,selective and ATP-competitive
      ≥36.6 mg/mL
  6. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR inhibitor
      ≥21.35 mg/mL
  7. Dovitinib (TKI-258, CHIR-258)
    A2168 Dovitinib (TKI-258, CHIR-258)
     2 Citation
    Target: FLT3|VEGFR|PDGFR|c-Kit|FGFR
    Summary: Multitargeted RTK inhibitor
      insoluble in H2O; insoluble in EtOH; ≥36.35 mg/mL
  8. Silvestrol
    A3818 Silvestrol
    Summary: Antineoplastic
      Soluble in DMSO
  9. BGJ398
    A3014 BGJ398
     1 Citation
    Target: FGFR
    Summary: FGFR inhibitor ,potent and selective
      insoluble in H2O; insoluble in EtOH; ≥7 mg/mL
  10. Ki8751
    A1821 Ki8751
    Target: VEGFR
    Summary: VEGFR-2 inhibitor,potent and selective
      ≥23.45 mg/mL

Items 21-30 of 45

Page
per page
Shop By
Now Shopping by
  1. Category Tyrosine Kinase Remove This Item
  2. Specificity Selective Remove This Item
Clear All
Shopping Options
Category
  1. Bcr-Abl 1 item
  2. Axl 1 item
  3. ALK 3item
  4. Broad Spectrum Protein Kinase Inhibitor 1 item
  5. c-FMS 1 item
  6. c-Kit 1 item
  7. c-MET 2item
  8. c-RET 2item
  9. CSF-1R 1 item
  10. EGFR 1 item
  11. FGFR 3item
  12. FLT3 4item
  13. HER2 1 item
  14. IGF1R 2item
  15. IRAK 2item
  16. ITK 1 item
  17. LRRK2 2item
  18. PDGFR 6item
  19. Spleen Tyrosine Kinase (Syk) 3item
  20. Src 2item
  21. Tie-2 2item
  22. Trk 1 item
  23. VEGFR 14item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Raf 3item
  3. Aurora Kinases 1 item
  4. CSF-1R 1 item
  5. FLT3 6item
  6. VEGFR 17item
  7. PDGFR 9item
  8. c-Kit 4item
  9. RET 2item
  10. IRAK 2item
  11. Bcr-Abl 4item
  12. FGFR 3item
  13. Insulin-like growth factor receptors(IGFRs) 1 item
  14. MET 1 item
  15. Src 4item
  16. Trk Receptors 2item
  17. EGFR 2item
  18. BMP and Other Activin Receptors 1 item
  19. JAK 1 item
  20. Syk 3item
  21. c-MET 3item
  22. PKC 1 item
  23. Ca2 /calmodulin-dependent protein kinases (CaMKs) 1 item
  24. LRRK2 2item
  25. Insulin and Insulin-like Receptors 1 item
  26. ALK 1 item
  27. PKG 1 item
  28. PKA 1 item
  29. Myosin light chain kinases (MLCKs) 1 item
  30. Tie-2 2item
  31. Ron 1 item
  32. c-Fyn 1 item
  33. Insulin Receptors 1 item
  34. IRG-1R 1 item
  35. ZAP-70 1 item
  36. c-Fms tyrosine kinase 1 item
  37. ITK 1 item
  38. DCLK2 1 item
Reported Experiments
  1. Animal Experiments 40item
  2. Cell Experiments 25item
Related Disease
  1. Acute Myeloid Leukemia 1 item
  2. Adrenocortical Carcinoma 1 item
  3. Advanced Renal Cell Carcinoma 1 item
  4. Autoimmune Diseases 1 item
  5. Bladder Cancer 2item
  6. Breast Cancer 9item
  7. Cancer 28item
  8. Cervical Cancer 1 item
  9. Clear Cell Renal Cell Carcinoma 1 item
  10. Colon Cancer 1 item
  11. Colon Carcinoma 3item
  12. Colorectal Cancer 8item
  13. Glioblastoma 3item
  14. Glioma 1 item
  15. Leukemia 1 item
  16. Liver Cancer 1 item
  17. Lung Cancer 4item
  18. Lung Carcinoma 2item
  19. Lymphoma 2item
  20. Melanoma 2item
  21. Multiple Myeloma 2item
  22. Myeloma 1 item
  23. Non-small Cell Lung Cancer 3item
  24. Ovarian Cancer 3item
  25. Pancreatic Cancer 2item
  26. Prostate Cancer 3item
  27. Pulmonary Arterial Hypertension 1 item
  28. Renal Cancer 2item
  29. Renal Cell Carcinoma 2item
  30. Thyroid Cancer 3item